Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Search Results for "Rna Interference Patents Dr Allen"

18:25 EDT 16th April 2014 | BioPortfolio

Original Source: Benitec - RNAi patent update

22 March 2011, Melbourne, Australia: Benitec Limited (ASX: BLT), a world leader in expressed gene silencing for human therapeutics, today announced further positive progress in its fundamental Graham family patent applications exclusively licensed from CSIRO worldwide for human therapeutics. These patents cover silencing of genes using DNA-directed RNA interference (ddRNAi). Progress on these patent applications further strengthens Benitec’s position with regards to both its revenue opportunities...

Matching Channels

Biosuperior Antibodies

After biosimilar versions of therapeutic proteins have become reality in Europe and in the US, now it’s the turn of therapeutic antibodies to be in the line of fire. Patents of the first wave of...

Tumor Necrosis Factor TNF Products

Tumor Necrosis Factor (TNF) and TNF receptor antagonists and agonists used to treat TNF-mediated inflammatory diseases such as rheumatoid arthritis or to treat cancer. TNF blockers are the commerc...

Coagulation Factors

Fourteen different blood coagulation factors are present in the body. Each plays a crucial role in the process described above. Some work to increase the activity level of the other factors while so...

Matching News

Sovaldi's Patent War

By Peter Geschek: Idenix Now that Sovaldi, Gilead Sciences (GILD) hepatitis C drug is approved and selling well, a number of companies remember that they have invented the drug. Lawsuits are flying...

RNA interference decreasing in value at the pharmaceutical market

According to The New York Times, the interest of big pharmaceutical companies in developing RNA interference-based therapeutic products is declining in favor of other solutions.

DNA-guided DNA interference by a prokaryotic Argonaute

RNA interference is widely distributed in eukaryotes and has a variety of functions, including antiviral defence and gene regulation. All RNA interference pathways use small single-stranded RNA (ssRNA...

Two-plasmon quantum interference

Researchers demonstrate unequivocal quantum interference between plasmons in a Hong–Ou–Mandel experiment. The results may be important for quantum information applications of plasmonics.

Burlington, Vt. - Fletcher Allen Recertified as Level 1 Trauma Center

Fletcher Allen Health Care has earned recertification as a Level 1 Trauma Center for adult patients by the American College of Surgeons (ACS).  The designation is the highest accreditat...

Advice on Biotech Patents For Research Companies

Written by an expert patent attorney, this article provides an overview of the use of patents in the biotech industry specifically for research companies. The Objective of Patents Patents provide prot...

So That's What "Non-Interference" Means: CMS Defines Loaded Term in Proposed Part D Rule

The 700-page Part D proposed rule does much more than change the "protected" class list. Among many other provisions, it spells out how CMS interprets the infamous "non-interference" clause.

Die Generalversammlung von Nobel Biocare folgt allen Anträgen des Verwaltungsrats

MedienmitteilungZÜRICH, SCHWEIZ - 26. MÄRZ 2014 Die Generalversammlung von Nobel Biocare folgt allen Anträgen des VerwaltungsratsDie Generalversammlung der Nobel Biocare Holding AG hat heute allen...

Matching PubMed Articles

Dendritic Cell Vaccine and Cancer Treatment: New Patents.

Dendritic cell (DC) immunotherapy has been used to treat various types of tumors. Although already in use in clinical practice, the mechanisms through which it acts need clarification. In addition, th...

Filed and granted Indian Patents in dentistry from 2005-2009: A critical analysis and review.

Background: Patent policies have proved to be extremely important for several countries to develop. India has achieved its global status since 2005; a critical analysis of the patents at IPO will help...

Separating the competitive and allelopathic components of interference : Theoretical principles.

The terms "competition" and "allelopathy" should be used in ways consistent with some set of criteria, perhaps those proposed in this discussion. Proposed proof of competitive interference includes: (...

Framing the patent troll debate.

The patent troll debate has reached a fevered pitch in the USA. This editorial seeks to frame the debate by pointing out the lack of clarity in defining patent trolls and their allegedly harmful actio...

Peptide nucleic acids: a review on recent patents and technology transfer.

Introduction: DNA/RNA-based drugs are considered of major interest in molecular diagnosis and nonviral gene therapy. In this field, peptide nucleic acids (PNAs, DNA analogs in which the sugar-phosphat...

Search Whole site using Google

Search BioPortfolio:
Advertisement Advertisement